Cargando…
Antipsychotics in off-label use: prescription practices, benefits and risks Results from APSY Oulu study
INTRODUCTION: Use of antipsychotics (APs) has increased worldwide during last decades. Main reason for this is off-label use, and especially the use of quetiapine for insomnia and anxiety. There is an insufficient amount of knowledge about the prescription habits and the effects of APs in off-label...
Autor principal: | Jääskeläinen, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405721/ http://dx.doi.org/10.1192/j.eurpsy.2023.648 |
Ejemplares similares
-
Off-label prescribing of antipsychotics: prescribing practices and clinical experiences of Finnish physicians
por: Rautio, N., et al.
Publicado: (2022) -
APSI scaphoid hemiarthroplasty – long-term results()
por: Santos, Filipe Lima, et al.
Publicado: (2018) -
Scaling up the APSI Membership
por: Kadam, Dinesh
Publicado: (2022) -
Off-label use of atypical antipsychotics- Where are we?
por: Vaz, R. P., et al.
Publicado: (2023) -
Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
por: Bastaki, Kholoud, et al.
Publicado: (2021)